e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Temporal trend analysis of TB treatment outcomes in the WHO European region
M. Dara, G. Sotgiu, A. Dadu, H. Kluge, M. Grzemska, R. Centis, L. D‘Ambrosio, G. B. Migliori (Copenhagen, Denmark; Tradate, Sassari, Italy; Geneva, Switzerland)
Source:
Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Session:
Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Session type:
Poster Discussion
Number:
3295
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Dara, G. Sotgiu, A. Dadu, H. Kluge, M. Grzemska, R. Centis, L. D‘Ambrosio, G. B. Migliori (Copenhagen, Denmark; Tradate, Sassari, Italy; Geneva, Switzerland). Temporal trend analysis of TB treatment outcomes in the WHO European region. Eur Respir J 2011; 38: Suppl. 55, 3295
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Tuberculosis treatment outcome monitoring in European Union countries: systematic review
Source: Eur Respir J 2013; 41: 635-643
Year: 2013
Unbiased clinical cluster analysis across a combined European and a Brazilian severe asthma (SA) population.
Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors
Year: 2018
Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010
An integrated MDR-TB management programme results in favourable outcomes in northern Taiwan
Source: Eur Respir J 2015; 45: 272-275
Year: 2015
Response to RD1 selected epitopes is associated to active tuberculosis. Results of a European multicentre hospital-based study: interim analysis of a European tuberculosis network (TBNET) study
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007
Time trend of asthma prevalence: ecological analysis of the investigations in schoolchildren in Turkey
Source: Eur Respir J 2006; 28: Suppl. 50, 240s
Year: 2006
Validation of clinical clusters for long-term mortality in two European COPD cohorts
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020
Health status burden of COPD - comparison across different countries and treatment settings
Source: Eur Respir J 2005; 26: Suppl. 49, 56s
Year: 2005
Response to RD1 selected epitopes is associated to active TB. Results of a European multicentre hospital-based study of the European tuberculosis network (TBNET)
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
The results of the TB control during of it epidemic in Ukraine on the base of the TB incidence in risk groups studying
Source: Eur Respir J 2003; 22: Suppl. 45, 518s
Year: 2003
Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Results of traditional and new regimens of MDR/XDR TB treatment: cohort analysis
Source: International Congress 2019 – Drug-resistant tuberculosis
Year: 2019
Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation
Source: Eur Respir J 2014; 43: 554-565
Year: 2013
Asthma in South African adolescents: a time trend and risk factor analysis over two decades
Source: ERJ Open Res, 7 (2) 00576-2020; 10.1183/23120541.00576-2020
Year: 2021
Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data.
Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies
Year: 2021
Late Breaking Abstract - The effect of comorbidity on the course and outcomes of COPD in observation in the primary health care, including on the background of the COVID-19 pandemic: a comparative analysis.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Has asthma control improved since AIRE? Results of a survey in 5 European countries
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007
Screening coverage and treatment loss to follow-up of Diabetes and Tuberculosis (TB) patients in hospitals with measures to integrate care of Diabetes and TB and those without integration measures in Malawi
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Hierarchical linear models for longitudinal change in COPD - is there an effect of differential dropout between treatment groups on estimated decline rates?
Source: Eur Respir J 2001; 18: Suppl. 33, 151s
Year: 2001
Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept